Immunopathogenesis of Dengue Virus Infection

Huan-Yao Lei; Trai-Ming Yeh, Julie Y. H.; Hsiao-Sheng Liu; Yee-Shin Lin; Shun-Hua Chen; Ching-Chuan Liu
September 2001
Journal of Biomedical Science;2001, Vol. 8 Issue 5, p377
Academic Journal
Dengue virus infection causes dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS), whose pathogeneses are not clearly understood. Current hypotheses of antibody-dependent enhancement, virus virulence, and IFN-γ/TNFα-mediated immunopathogenesis are insufficient to explain clinical manifestations of DHF/DSS such as thrombocytopenia and hemoconcentration. Dengue virus infection induces transient immune aberrant activation of CD4/CD8 ratio inversion and cytokine overproduction, and infection of endothelial cells and hepatocytes causes apoptosis and dysfunction of these cells. The coagulation and fibrinolysis systems are also activated after dengue virus infection. We propose a new hypothesis for the immunopathogenesis for dengue virus infection. The aberrant immune responses not only impair the immune response to clear the virus, but also result in overproduction of cytokines that affect monocytes, endothelial cells, and hepatocytes. Platelets are destroyed by crossreactive anti-platelet autoantibodies. Dengue-virus-induced vasculopathy and coagulopathy must be involved in the pathogenesis of hemorrhage, and the unbalance between coagulation and fibrinolysis activation increases the likelihood of severe hemorrhage in DHF/DSS. Hemostasis is maintained unless the dysregulation of coagulation and fibrinolysis persists. The overproduced IL-6 might play a crucial role in the enhanced production of anti-platelet or anti-endothelial cell autoantibodies, elevated levels of tPA, as well as a deficiency in coagulation. Capillary leakage is triggered by the dengue virus itself or by antibodies to its antigens. This immunopathogenesis of DHF/DSS can account for specific characteristics of clinical, pathologic, and epidemiological observations in dengue virus infection.Copyright © 2001 National Science Council, ROC and S. Karger AG, Basel


Related Articles

  • Immature Dengue Virus: A Veiled Pathogen? Rodenhuis-Zybert, Izabela A.; van der Schaar, Hilde M.; da Silva Voorham, Júlia M.; van der Ende-Metselaar, Heidi; Huan-Yao Lei; Wilschut, Jan; Smit, Jolanda M. // PLoS Pathogens;Jan2010, Vol. 6 Issue 1, p1 

    Cells infected with dengue virus release a high proportion of immature prM-containing virions. In accordance, substantial levels of prM antibodies are found in sera of infected humans. Furthermore, it has been recently described that the rates of prM antibody responses are significantly higher...

  • Prediction of protein-protein interactions in dengue virus coat proteins guided by low resolution cryoEM structures. Gadkari, Rupali A.; Srinivasan, Narayanaswamy // BMC Structural Biology;2010, Vol. 10, p17 

    Background: Dengue virus along with the other members of the flaviviridae family has reemerged as deadly human pathogens. Understanding the mechanistic details of these infections can be highly rewarding in developing effective antivirals. During maturation of the virus inside the host cell, the...

  • Cross-Reactive Memory CD8+ T Cells Alter the Immune Response to Heterologous Secondary Dengue Virus Infections in Mice in a Sequence- Specific Manner. Beaumier, Coreen M.; Mathew, Anuja; Bashyam, Hema S.; Rothman, Alan L. // Journal of Infectious Diseases;2/15/2008, Vol. 197 Issue 4, p608 

    Dengue virus is the causative agent of dengue fever and the more-severe dengue hemorrhagic fever (DHF). Human studies suggest that the increased risk of DHF during secondary infection is due to immunopathology partially mediated by cross-reactive memory T cells from the primary infection. To...

  • Seroepidemiology of Dengue Virus in Mayotte, Indian Ocean, 2006. Sissoko, Daouda; Ezzedine, Khaled; Giry, Claude; Moendandzé, Amrat; Lernout, Tinne; D'Ortenzio, Eric; Pettinelli, François; Malvy, Denis // PLoS ONE;2010, Vol. 5 Issue 11, p1 

    Background: Although Dengue virus (DENV) circulation had been documented in neighbouring South-western Indian Ocean Islands, its presence in Mayotte is poorly characterised. To address this issue, we aimed to assess the seroprevalence of dengue IgG antibodies (DENV-IgG Ab) among the population...

  • Rational Design of a Live Attenuated Dengue Vaccine: 2′-O-Methyltransferase Mutants Are Highly Attenuated and Immunogenic in Mice and Macaques. Züst, Roland; Dong, Hongping; Li, Xiao-Feng; Chang, David C.; Zhang, Bo; Balakrishnan, Thavamalar; Toh, Ying-Xiu; Jiang, Tao; Li, Shi-Hua; Deng, Yong-Qiang; Ellis, Brett R.; Ellis, Esther M.; Poidinger, Michael; Zolezzi, Francesca; Qin, Cheng-Feng; Shi, Pei-Yong; Fink, Katja // PLoS Pathogens;Aug2013, Vol. 9 Issue 8, p1 

    Dengue virus is transmitted by Aedes mosquitoes and infects at least 100 million people every year. Progressive urbanization in Asia and South-Central America and the geographic expansion of Aedes mosquito habitats have accelerated the global spread of dengue, resulting in a continuously...

  • IMMUNOLOGICAL EVALUATION OF TWO DIFFERENT CONSTRUCTS OF DENGUE-1-P64k CHIMERIC PROTEINS. Hermida, Lisset; Rodríguez, Rayner; Lazo, Laura; Bernardo, Lídice; Silva, Ricardo; Zulueta, Aída; López, Carlos; Martín, Jorge; Valdés, Iris; Del Rosario, Delfina; Chinea, Glay; Guzmán, Guadalupe; Guillén, Gerardo // Revista VacciMonitor (Vacunología y Temas Afines);Oct2002, Vol. 11 Issue 4, p1 

    The Dengue viruses (DEN) are human pathogens that cause a disease called Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS). It has been demonstrated that the E recombinant protein from DEN is capable to elicit high neutralizing antibodies and a protective immunity in mice. In this...

  • Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus. Lazo, Laura; Gil, Lázaro; Lopez, Carlos; Valdes, Iris; Marcos, Ernesto; Álvarez, Mayling; Blanco, Aracelys; Romero, Yaremis; Falcon, Viviana; Guzmán, María G.; Guillén, Gerardo; Hermida, Lisset // Archives of Virology;Oct2010, Vol. 155 Issue 10, p1587 

    In this study, we evaluate in mice a novel formulation containing nucleocapsid-like particles of dengue-2 virus (recNLP) co-immunized with a chimeric protein composed of the dengue-4 envelope domain III fused twice within the meningococcal P64k protein of Neisseria meningitidis (PD24). The...

  • INFLUENCE OF DIFFERENT ADJUVANTS IN THE IMMUNOLOGICAL RESPONSE AGAINST DENGUE 2 VIRUS WITH A FUSION PROTEIN. López, C.; Rodriguez, R.; Hermida, L.; Bernardo, L.; Martin, J.; Guerra, I.; Lazo, L.; Zulueta, A.; Guillen, G.; Guzman, G. // Revista VacciMonitor (Vacunología y Temas Afines);Oct2002, Vol. 11 Issue 4, p1 

    Dengue epidemics caused by the four dengue virus serotypes continue to pose a major public health problem in most tropical and subtropical regions. A safe and effective vaccine against dengue is still not available. In our group different fusion proteins including a fragment of the envelope (E)...

  • In silico Molecular Modelling and Docking Studies on Therapeutic Target Non Structural Protein 3 (NS3) of Dengue Virus 1. Komala, Sakamoori; Ravi, Sahukari; Usnantaj, Patan; Shanmugam, Bhasha; Subbaiah, Ganjikunta Venkata; Reddy, Kesireddy Sathyavelu // International Journal of Pharmaceutical Sciences Review & Resear;Nov/Dec2014, Vol. 29 Issue 1, p37 

    Dengue virus (DENV) is a family member of flaviviruses, transfer their pathogenecity to humans by the vector mosquitoes and it is showing similar positive sense genomic RNA as such flavivirus, encodes single polyprotein in order to synthesize structural and non structural proteins. Non...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics